Setterwalls represented Abboxia in the dispute. In April 2019 the Medical Products Agency decided to reject Abboxias’ application for marketing authorisation for parallel import of pharmaceuticals…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now